IDO-2 (Figure 1B) and TDO-2 (Figure 1C) expression showed a similar pattern, with high expression in diffuse large B-cell lymphoma and low expression in acute myeloid leukemia. Here, TDO2 is linked to diffuse large B-cell lymphoma.